Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, Weide B, Gutzmer R, Becker JC, Kiecker F, Daehling A, Funkner F, Heidenreich R, Kays SK, Klinkhardt U, Scheel B, Schoenborn-Kellenberger O, Seibel T, Stosnach C, Strack T, Gnad-Vogt U (2019)
Publication Type: Conference contribution
Publication year: 2019
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.AM2019-LB-021
APA:
Eigentler, T., Krauss, J., Schreiber, J., Weishaupt, C., Terheyden, P., Heinzerling, L.,... Gnad-Vogt, U. (2019). Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors. In CANCER RESEARCH. Atlanta, GA, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Eigentler, Thomas, et al. "Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors." Proceedings of the AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology, Atlanta, GA PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2019.
BibTeX: Download